U.S. flag

An official website of the United States government

NM_000202.8(IDS):c.641C>T (p.Thr214Met) AND not provided

Germline classification:
Benign (3 submissions)
Last evaluated:
May 5, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000587097.14

Allele description [Variation Report for NM_000202.8(IDS):c.641C>T (p.Thr214Met)]

NM_000202.8(IDS):c.641C>T (p.Thr214Met)

Genes:
LOC106050102:IDS recombination region [Gene]
IDS:iduronate 2-sulfatase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_000202.8(IDS):c.641C>T (p.Thr214Met)
HGVS:
  • NC_000023.11:g.149498174G>A
  • NG_011900.3:g.12161C>T
  • NG_042264.1:g.11529G>A
  • NM_000202.8:c.641C>TMANE SELECT
  • NM_001166550.4:c.371C>T
  • NM_006123.5:c.641C>T
  • NP_000193.1:p.Thr214Met
  • NP_000193.1:p.Thr214Met
  • NP_001160022.1:p.Thr124Met
  • NP_006114.1:p.Thr214Met
  • NC_000023.10:g.148579705G>A
  • NM_000202.4:c.641C>T
  • NM_000202.5:c.641C>T
  • NM_000202.6:c.641C>T
  • NM_000202.7:c.641C>T
  • NR_104128.2:n.810C>T
Protein change:
T124M
Links:
dbSNP: rs61736892
NCBI 1000 Genomes Browser:
rs61736892
Molecular consequence:
  • NM_000202.8:c.641C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001166550.4:c.371C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006123.5:c.641C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_104128.2:n.810C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000695964Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Benign
(Jun 26, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

LabCorp Variant Classification Summary - May 2015.docx,

Citation Link,

SCV001800280Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) - VKGL Data-share Consensus
no assertion criteria provided
Likely benigngermlineclinical testing

SCV001949054GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Benign
(May 5, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients.

Chkioua L, Khedhiri S, Turkia HB, Tcheng R, Froissart R, Chahed H, Ferchichi S, Ben Dridi MF, Vianey-Saban C, Laradi S, Miled A.

Diagn Pathol. 2011 Jun 3;6:47. doi: 10.1186/1746-1596-6-47.

PubMed [citation]
PMID:
21639919
PMCID:
PMC3135498

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000695964.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: The IDS c.641C>T (p.Thr214Met) variant involves the alteration of a non-conserved nucleotide and 2/4 in silico tools predict a benign outcome for this variant. This variant was found in 444/87744 control chromosomes (12 homozygotes, 100 hemizygotes) at a frequency of 0.0050602, which is approximately 2 times the estimated maximal expected allele frequency of a pathogenic IDS variant (0.0028868), suggesting this variant is likely a benign polymorphism. A publication, Chkioua_2011, cites the variant in an affected individual, who was homozygous for the pathogenic R88P variant. This variant also co-occurred with a pathogenic variant, c.1402C>T (p.R468W) in a sample tested at our laboratory. In addition, multiple clinical diagnostic laboratories classified this variant as benign. Taken together, this variant is classified as benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) - VKGL Data-share Consensus, SCV001800280.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV001949054.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is associated with the following publications: (PMID: 21605424, 27884173, 27695081, 27896113, 31019283, 32448126)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024